Here we demonstrate that an apparent discrepancy in CBF (from ASL) and CMRglu (from [18F]-FDG PET) following high-dose administration of clenbuterol in healthy volunteers is caused by within-scan rising plasma glucose concentrations. With simulation-based correction, post-clenbuterol CBF changes from ASL agree with blood flow estimates from [18F]-FDG PET, without increase in CMRGlu. ASL-MRI may therefore provide a valuable tool for monitoring the central effects of β2-adrenergic receptor activation in larger, future studies on both healthy volunteers and patients with neurodegenerative disorders.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords